Rho Kinase Inhibitors for Glaucoma and Optic Neuropathy Treatment: Enzyme Activity, Cell Effects, IOP-Lowering and Neuroprotection Perspectives. OAJO 2022, 7 (1), 1-23. https://doi.org/10.23880/oajo-16000233.